ZFIN Image: Mendelson et al., 2015, Fig. 4

Image

Figure Caption

Fig. 4

Expression of Sphk2 in YSL can rescue normal cardiogenesis. Shown are representative embryos following in situ hybridization for myl7 transcripts at 32 hpf. (A) Wildtype (WT) embryos (25/25, 100%) display normal cardiac development. (B) Injection of 250 pg of sphk2 mRNA into the single cell (65/65, 100%) or (C) targeted to the YSL (51/51, 100%) does not alter cardiac development. (D) All maternal/zygotic sphk2^MZ embryos show the cardia bifid phenotype (0/40 embryos are normal, 0%). (E) Injection of 250 pg sphk2 mRNA into the 1-cell stage embryos was able to rescue the bifid phenotype as shown by the presence of cardiac tissue at the midline (7/44 embryos, 16%). (F) Targeting 250 pg sphk2 mRNA specifically into the YSL (confirmed by co-injection of rhodamine dextran tracer, as documented in G) was able to rescue the bifid phenotype (19/88 embryos, 22%). (H) In contrast, injection of mRNA encoding a predicted kinase dead Sphk2 (KD) into the fertilized egg (56/56, 100%) or (I) targeted to the YSL (43/43, 100%) failed to rescue the bifid phenotype. (J) Injection of 1 ng S1P in the fertilized egg (47/47, 100%) or YSL (47/47, 100%, not shown) did not alter cardiac development of wildtype embryos, whereas (K) injection of 1 ng S1P into the fertilized egg (15/51, 29%) or (L) targeted to the YSL (9/32, 28%) was able to rescue the bifid phenotype of sphk2^MZ embryos.

Figure Data

Expression / Labeling details

Phenotype details

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Dev. Dyn.